supported by National Natural Science Foundation of China(No.81773656 and U1608283);Liaoning Revitalization Talents Program(No XLYC1808017,China);Key projects of Technology bureau in Shenyang(No.18400408,China);Key projects of Liaoning Province Department of Education(No.2017LZD03,China);111 Project(D20029,China)
A commercial albumin-bound paclitaxel nano-formulation has been considered a gold standard against breast cancer.However,its application still restricted unfavorable pharmacokinetics and the immunogenicity of exogenou...